These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24723218)

  • 1. Moderating factors for the effectiveness of group art therapy for schizophrenia: secondary analysis of data from the MATISSE randomised controlled trial.
    Leurent B; Killaspy H; Osborn DP; Crawford MJ; Hoadley A; Waller D; King M
    Soc Psychiatry Psychiatr Epidemiol; 2014 Nov; 49(11):1703-10. PubMed ID: 24723218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE).
    Crawford MJ; Killaspy H; Barnes TR; Barrett B; Byford S; Clayton K; Dinsmore J; Floyd S; Hoadley A; Johnson T; Kalaitzaki E; King M; Leurent B; Maratos A; O'Neill FA; Osborn D; Patterson S; Soteriou T; Tyrer P; Waller D;
    Health Technol Assess; 2012; 16(8):iii-iv, 1-76. PubMed ID: 22364962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MATISSE study: a randomised trial of group art therapy for people with schizophrenia.
    Crawford MJ; Killaspy H; Kalaitzaki E; Barrett B; Byford S; Patterson S; Soteriou T; O'Neill FA; Clayton K; Maratos A; Barnes TR; Osborn D; Johnson T; King M; Tyrer P; Waller D
    BMC Psychiatry; 2010 Aug; 10():65. PubMed ID: 20799930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial.
    Crawford MJ; Killaspy H; Barnes TR; Barrett B; Byford S; Clayton K; Dinsmore J; Floyd S; Hoadley A; Johnson T; Kalaitzaki E; King M; Leurent B; Maratos A; O'Neill FA; Osborn DP; Patterson S; Soteriou T; Tyrer P; Waller D;
    BMJ; 2012 Feb; 344():e846. PubMed ID: 22374932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity groups for people with schizophrenia: a randomized controlled trial.
    Dean M; Weston AR; Osborn DP; Willis S; Patterson S; Killaspy H; Leurent B; Crawford MJ
    J Ment Health; 2014 Aug; 23(4):171-5. PubMed ID: 24660971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity.
    Montag C; Haase L; Seidel D; Bayerl M; Gallinat J; Herrmann U; Dannecker K
    PLoS One; 2014; 9(11):e112348. PubMed ID: 25393414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial.
    Priebe S; Savill M; Reininghaus U; Wykes T; Bentall R; Lauber C; McCrone P; Röhricht F; Eldridge S
    BMC Psychiatry; 2013 Jan; 13():26. PubMed ID: 23317474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial.
    Chatterjee S; Naik S; John S; Dabholkar H; Balaji M; Koschorke M; Varghese M; Thara R; Weiss HA; Williams P; McCrone P; Patel V; Thornicroft G
    Lancet; 2014 Apr; 383(9926):1385-94. PubMed ID: 24612754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Art therapy for schizophrenia or schizophrenia-like illnesses.
    Ruddy R; Milnes D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003728. PubMed ID: 16235338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of motivation interviewing using a group art therapy program on negative symptoms of schizophrenia.
    Cho JM; Lee K
    Arch Psychiatr Nurs; 2018 Dec; 32(6):878-884. PubMed ID: 30454632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: multicentre randomised controlled trial.
    Priebe S; Savill M; Wykes T; Bentall RP; Reininghaus U; Lauber C; Bremner S; Eldridge S; Röhricht F
    Br J Psychiatry; 2016 Jul; 209(1):54-61. PubMed ID: 27151073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
    Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Art therapy for schizophrenia or schizophrenia-like illnesses.
    Ruddy R; Milnes D
    Cochrane Database Syst Rev; 2003; (2):CD003728. PubMed ID: 12804485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial.
    Morrison AP; Turkington D; Pyle M; Spencer H; Brabban A; Dunn G; Christodoulides T; Dudley R; Chapman N; Callcott P; Grace T; Lumley V; Drage L; Tully S; Irving K; Cummings A; Byrne R; Davies LM; Hutton P
    Lancet; 2014 Apr; 383(9926):1395-403. PubMed ID: 24508320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.
    Kang R; Wu Y; Li Z; Jiang J; Gao Q; Yu Y; Gao K; Yan Y; He Y
    Psychopathology; 2016; 49(5):345-355. PubMed ID: 27584836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.